H Kahal
The effect of treatment of liraglutide on quality of life and depression in young obese women with PCOS and controls
Kahal, H; Kilpatrick, ES; Rigby, A; Coady, AM; Atkin, SL
Authors
ES Kilpatrick
A Rigby
AM Coady
SL Atkin
Abstract
Polycystic ovary syndrome (PCOS) is associated with reduced quality of life (QoL), though the role of associated obesity is unclear. In this study we examined the effects of six months treatment with liraglutide, 1.8 mg od, on obesity, depression and QoL in young women with PCOS and obesity compared to age- and weight-matched controls. In a cross-sectional study, 36 women were recruited (19 PCOS, 17 controls), age 33.9 ± 6.7 vs. 33.5 ± 7.1 yr, and weight 102.1 ± 17.1 vs. 100.4 ± 15.1 kg, respectively. PCOS was diagnosed according to the Rotterdam criteria. Depression was measured using the Centre for Epidemiologic Studies Depression Scale (CES-D). QoL was measured using the World Health Organization QoL questionnaire (WHOQOL-BREF). At baseline there was no difference in QoL or CES-D scores between the two groups. At six months, weight was reduced by 3.0 ± 4.2 kg, p = .01, in the PCOS group and 3.8 ± 3.4 kg, p = .001, in controls. Psychological health improved in the PCOS group (percentage change 11.3%, p smaller than .02). Combining the two groups revealed significant improvement (p smaller than .05) in physical (82.6 ± 11.2 vs. 78.9 ± 13.6), psychological (62.4 ± 16.5 vs. 57.5 ± 16.4) and social health (76.6 ± 15.3 vs. 71 ± 16.8) components of the WHOQOL-BREF at six months. Weight loss is associated with an improvement in QoL; and when matched for age and obesity, PCOS was not independently associated with reduced QoL or depression.
Citation
Kahal, H., Kilpatrick, E., Rigby, A., Coady, A., & Atkin, S. (2019). The effect of treatment of liraglutide on quality of life and depression in young obese women with PCOS and controls. Gynecological Endocrinology, 35(2), 142-145. https://doi.org/10.1080/09513590.2018.1505848
Journal Article Type | Article |
---|---|
Acceptance Date | Jul 25, 2018 |
Online Publication Date | Jan 1, 2019 |
Publication Date | Jan 1, 2019 |
Deposit Date | Jul 26, 2018 |
Publicly Available Date | Jan 2, 2020 |
Print ISSN | 0951-3590 |
Publisher | Taylor and Francis |
Peer Reviewed | Peer Reviewed |
Volume | 35 |
Issue | 2 |
Pages | 142-145 |
DOI | https://doi.org/10.1080/09513590.2018.1505848 |
Keywords | PCOS; Liraglutide; Obesity; Quality of life; Depression |
Public URL | https://hull-repository.worktribe.com/output/947763 |
Publisher URL | https://www.tandfonline.com/doi/full/10.1080/09513590.2018.1505848 |
Contract Date | Jul 26, 2018 |
Files
Article
(207 Kb)
PDF
Copyright Statement
©2018 The authors
V3 Accepted PCOS Lir QoL Paper 18.07.2018
(77 Kb)
Document
Copyright Statement
©2018 University of Hull
You might also like
Platelet function following induced hypoglycaemia in type 2 diabetes
(2018)
Journal Article
Metabolic and proteomic signatures of hypoglycaemia in type 2 diabetes
(2018)
Journal Article
Downloadable Citations
About Repository@Hull
Administrator e-mail: repository@hull.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search